Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alefacept for Chronic Plaque Psoriasis After Anti-TNF Failure
NCT00953329Phase 4Terminated
- Sponsor
- John Murray
- Start
- Feb 2008
- Primary completion
- Dec 2008
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 4 trial of alefacept in psoriasis, sponsored by John Murray. Started Feb 2008; status: terminated.
02
Drugs
alefacept
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00953329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953329.